22nd European Congress on Alternatives to Animal Testing / 19th Annual Congress of EUSAAT

  • Other
Thursday 10 October 2019 to Sunday 13 October 2019
Linz, Austria

This year's EUSAAT Congress will focus on a number of topics, including:

  • Refinement: best practice approaches, animal welfare, avoidance of severe suffering, culture of care
  • Reduction: transparency, reproducibility and translational aspects (species differences)
  • Replacement: advanced technologies for implementing the 3Rs: bio-printing,  -omics technologies, systems biology approaches, IT and big data
  • Banning the 90-day dog study for the safety testing of human drugs and pharmaceuticals
  • 3Rs in education and academia
  • 3R Centers in Europe & international - national and local centers
  • International progress in 3Rs research: New Funding Initiatives & Global Cooperation
  • 3D Models & multi-organ-chips (MOC), human-organ-chips (HOC)
  • Biological barriers: e.g. lung, gut, kidney & skin epithelia, blood-brain & blood-saliva barriers
  • In Silico Models: toxicology & efficacy of drugs, chemicals & cosmetics, new approaches for biomedical research
  • Disease models using HUMAN cells, tissues and organs
  • Efficacy and safety testing of drugs, medical devices & biopharmaceutics (incl. vaccines, blood components, allergenics, somatic cells, gene therapies, tissues and living cells used in therapy)
  • REACH - the most frequently used alternatives: Read Across, WoE (Weight of Evidence), QSAR
  • Advanced safety testing of cosmetics and consumer products (e. g. toys)
  • Alternatives to animal testing in food safety, nutrition and efficacy
  • Specific Endpoints of Toxicity: repeated-dose toxicity, inhalation, sensitization, reproductive & developmental toxicity (mEST & hEST), carcinogenesis, nanotoxicology
  • Neurotoxicity & Developmental Neurotoxicity (DNT)
  • Ecotoxicology
  • Stem cell models and technology (hIPS, ES, mES, mIPS…)
  • Implementing EU Dir 63/2010 - update
  • Ethical & legal issues
  • Advanced GMO models – CRISPR/Cas in vivo & in vitro
  • Initiative for Implementing Serum Free Culture Media
  • Publication policies regarding animal experiments and the 3Rs principles
  • An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment: Results of the in3 project
  • Vaccines: safety testing & the 3Rs

To find out more, visit the Congress website.